Coexpression cluster:C342: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 11:20, 17 September 2013
Full id: C342_xeroderma_b_B_splenic_plasma_Burkitt_thymus
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0030889 | negative regulation of B cell proliferation | 0.0135934311345815 |
GO:0009986 | cell surface | 0.0135934311345815 |
GO:0035197 | siRNA binding | 0.0135934311345815 |
GO:0046649 | lymphocyte activation | 0.0135934311345815 |
GO:0045321 | leukocyte activation | 0.0135934311345815 |
GO:0001775 | cell activation | 0.0135934311345815 |
GO:0045359 | positive regulation of interferon-beta biosynthetic process | 0.0135934311345815 |
GO:0032608 | interferon-beta production | 0.0135934311345815 |
GO:0045357 | regulation of interferon-beta biosynthetic process | 0.0135934311345815 |
GO:0001782 | B cell homeostasis | 0.0135934311345815 |
GO:0045356 | positive regulation of interferon-alpha biosynthetic process | 0.0135934311345815 |
GO:0045350 | interferon-beta biosynthetic process | 0.0135934311345815 |
GO:0045354 | regulation of interferon-alpha biosynthetic process | 0.0135934311345815 |
GO:0032607 | interferon-alpha production | 0.0135934311345815 |
GO:0045349 | interferon-alpha biosynthetic process | 0.0135934311345815 |
GO:0050869 | negative regulation of B cell activation | 0.0135934311345815 |
GO:0045416 | positive regulation of interleukin-8 biosynthetic process | 0.0135934311345815 |
GO:0007130 | synaptonemal complex assembly | 0.0135934311345815 |
GO:0007129 | synapsis | 0.0144640387975788 |
GO:0032606 | interferon type I production | 0.0144640387975788 |
GO:0045414 | regulation of interleukin-8 biosynthetic process | 0.0144640387975788 |
GO:0045351 | interferon type I biosynthetic process | 0.0144640387975788 |
GO:0042228 | interleukin-8 biosynthetic process | 0.0144640387975788 |
GO:0045078 | positive regulation of interferon-gamma biosynthetic process | 0.0144640387975788 |
GO:0002260 | lymphocyte homeostasis | 0.0144640387975788 |
GO:0030888 | regulation of B cell proliferation | 0.0144640387975788 |
GO:0050794 | regulation of cellular process | 0.0144640387975788 |
GO:0002376 | immune system process | 0.0144640387975788 |
GO:0032637 | interleukin-8 production | 0.0144640387975788 |
GO:0050672 | negative regulation of lymphocyte proliferation | 0.0144640387975788 |
GO:0032945 | negative regulation of mononuclear cell proliferation | 0.0144640387975788 |
GO:0045072 | regulation of interferon-gamma biosynthetic process | 0.0152845094127478 |
GO:0000795 | synaptonemal complex | 0.0155828295736444 |
GO:0042095 | interferon-gamma biosynthetic process | 0.0155828295736444 |
GO:0001776 | leukocyte homeostasis | 0.0160671495404434 |
GO:0050789 | regulation of biological process | 0.0160671495404434 |
GO:0048872 | homeostasis of number of cells | 0.0165194171830189 |
GO:0051607 | defense response to virus | 0.0171554937858324 |
GO:0032609 | interferon-gamma production | 0.017565387589091 |
GO:0042100 | B cell proliferation | 0.017565387589091 |
GO:0004871 | signal transducer activity | 0.017565387589091 |
GO:0060089 | molecular transducer activity | 0.017565387589091 |
GO:0042127 | regulation of cell proliferation | 0.017565387589091 |
GO:0051250 | negative regulation of lymphocyte activation | 0.0175894684695822 |
GO:0003727 | single-stranded RNA binding | 0.0181021819400095 |
GO:0065007 | biological regulation | 0.0192416850047778 |
GO:0050864 | regulation of B cell activation | 0.0216552828916914 |
GO:0000794 | condensed nuclear chromosome | 0.0262791975789329 |
GO:0007127 | meiosis I | 0.0273988804587277 |
GO:0042108 | positive regulation of cytokine biosynthetic process | 0.0328333983870052 |
GO:0050670 | regulation of lymphocyte proliferation | 0.0328333983870052 |
GO:0032944 | regulation of mononuclear cell proliferation | 0.0328333983870052 |
GO:0008283 | cell proliferation | 0.0350210979489749 |
GO:0009897 | external side of plasma membrane | 0.0364814455963035 |
GO:0000793 | condensed chromosome | 0.0364814455963035 |
GO:0032943 | mononuclear cell proliferation | 0.0364814455963035 |
GO:0045727 | positive regulation of translation | 0.0364814455963035 |
GO:0046651 | lymphocyte proliferation | 0.0364814455963035 |
GO:0003725 | double-stranded RNA binding | 0.0364814455963035 |
GO:0007059 | chromosome segregation | 0.0392770992516106 |
GO:0042035 | regulation of cytokine biosynthetic process | 0.0392770992516106 |
GO:0031328 | positive regulation of cellular biosynthetic process | 0.0392770992516106 |
GO:0042113 | B cell activation | 0.0392944123856529 |
GO:0044454 | nuclear chromosome part | 0.041126194104434 |
GO:0042089 | cytokine biosynthetic process | 0.041126194104434 |
GO:0042107 | cytokine metabolic process | 0.041126194104434 |
GO:0051327 | M phase of meiotic cell cycle | 0.041126194104434 |
GO:0007126 | meiosis | 0.041126194104434 |
GO:0009891 | positive regulation of biosynthetic process | 0.041126194104434 |
GO:0051321 | meiotic cell cycle | 0.041126194104434 |
GO:0048522 | positive regulation of cellular process | 0.0420029648832667 |
GO:0051249 | regulation of lymphocyte activation | 0.0427493305344138 |
GO:0003723 | RNA binding | 0.0427493305344138 |
GO:0050865 | regulation of cell activation | 0.0436126357869517 |
GO:0007154 | cell communication | 0.0436126357869517 |
GO:0051247 | positive regulation of protein metabolic process | 0.0452925725332192 |
GO:0048518 | positive regulation of biological process | 0.0474896897675038 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|---|---|
lymphocyte of B lineage | 3.65e-45 | 24 |
pro-B cell | 3.65e-45 | 24 |
lymphocyte | 5.94e-24 | 53 |
common lymphoid progenitor | 5.94e-24 | 53 |
nucleate cell | 4.98e-23 | 55 |
mature B cell | 5.47e-23 | 2 |
pre-B-II cell | 5.47e-23 | 2 |
transitional stage B cell | 5.47e-23 | 2 |
small pre-B-II cell | 5.47e-23 | 2 |
immature B cell | 5.47e-23 | 2 |
lymphoid lineage restricted progenitor cell | 3.39e-20 | 52 |
precursor B cell | 1.14e-15 | 3 |
antibody secreting cell | 1.40e-12 | 1 |
plasma cell | 1.40e-12 | 1 |
plasmablast | 1.40e-12 | 1 |
B-1 B cell | 3.45e-12 | 1 |
nongranular leukocyte | 3.98e-10 | 115 |
leukocyte | 2.47e-08 | 136 |
hematopoietic lineage restricted progenitor cell | 6.48e-08 | 120 |
hematopoietic oligopotent progenitor cell | 8.42e-07 | 161 |
hematopoietic multipotent progenitor cell | 8.42e-07 | 161 |
Ontology term | p-value | n |
---|---|---|
hemopoietic organ | 9.59e-39 | 7 |
immune organ | 9.59e-39 | 7 |
spleen | 1.32e-33 | 3 |
gastrointestinal system mesentery | 1.32e-33 | 3 |
stomach region | 1.32e-33 | 3 |
mesentery | 1.32e-33 | 3 |
gastrointestinal system serosa | 1.32e-33 | 3 |
mesentery of stomach | 1.32e-33 | 3 |
gut mesentery | 1.32e-33 | 3 |
dorsal mesentery | 1.32e-33 | 3 |
dorsal mesogastrium | 1.32e-33 | 3 |
peritoneal cavity | 1.32e-33 | 3 |
spleen primordium | 1.32e-33 | 3 |
stomach | 5.05e-13 | 8 |
food storage organ | 5.05e-13 | 8 |
vermiform appendix | 1.96e-12 | 1 |
caecum | 1.96e-12 | 1 |
midgut | 1.96e-12 | 1 |
tonsil | 2.46e-12 | 1 |
mucosa-associated lymphoid tissue | 2.46e-12 | 1 |
lymphoid tissue | 2.46e-12 | 1 |
tonsillar ring | 2.46e-12 | 1 |
thymus | 1.05e-11 | 4 |
hemolymphoid system gland | 1.05e-11 | 4 |
thymic region | 1.05e-11 | 4 |
pharyngeal gland | 1.05e-11 | 4 |
thymus primordium | 1.05e-11 | 4 |
chordate pharynx | 2.47e-10 | 10 |
pharyngeal region of foregut | 2.47e-10 | 10 |
pharynx | 1.91e-09 | 11 |
mixed endoderm/mesoderm-derived structure | 2.40e-09 | 29 |
cavity lining | 7.26e-09 | 12 |
serous membrane | 7.26e-09 | 12 |
intraembryonic coelom | 7.26e-09 | 12 |
pharyngeal epithelium | 4.19e-08 | 6 |
gastrointestinal system | 5.00e-07 | 25 |
Ontology term | p-value | n |
---|---|---|
lymphoma | 1.16e-27 | 10 |
genetic disease | 7.03e-13 | 1 |
monogenic disease | 7.03e-13 | 1 |
xeroderma pigmentosum | 7.03e-13 | 1 |
anemia | 1.57e-12 | 1 |
acute leukemia | 3.08e-12 | 1 |
lymphatic system cancer | 3.45e-12 | 1 |
lymphosarcoma | 3.45e-12 | 1 |
hematologic cancer | 1.91e-07 | 51 |
immune system cancer | 1.91e-07 | 51 |
hematopoietic system disease | 6.80e-07 | 2 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 9.50746e-05 |
MA0004.1 | 0.080382 |
MA0006.1 | 0.107826 |
MA0007.1 | 0.0722718 |
MA0009.1 | 0.385713 |
MA0014.1 | 0.000209122 |
MA0017.1 | 0.601639 |
MA0019.1 | 0.158371 |
MA0024.1 | 0.303271 |
MA0025.1 | 0.497679 |
MA0027.1 | 1.91867 |
MA0028.1 | 0.121511 |
MA0029.1 | 0.852369 |
MA0030.1 | 0.30925 |
MA0031.1 | 0.723388 |
MA0038.1 | 0.818715 |
MA0040.1 | 1.55443 |
MA0041.1 | 1.54033 |
MA0042.1 | 0.934037 |
MA0043.1 | 0.38597 |
MA0046.1 | 0.376892 |
MA0048.1 | 0.181863 |
MA0050.1 | 0.93692 |
MA0051.1 | 0.808446 |
MA0052.1 | 0.325534 |
MA0055.1 | 0.233188 |
MA0056.1 | 0 |
MA0057.1 | 0.0894026 |
MA0058.1 | 0.16729 |
MA0059.1 | 0.672433 |
MA0060.1 | 0.097271 |
MA0061.1 | 3.38674 |
MA0063.1 | 0 |
MA0066.1 | 0.413239 |
MA0067.1 | 0.661236 |
MA0068.1 | 0.192805 |
MA0069.1 | 0.373781 |
MA0070.1 | 0.364788 |
MA0071.1 | 0.358524 |
MA0072.1 | 0.361192 |
MA0073.1 | 1.02142e-06 |
MA0074.1 | 0.405541 |
MA0076.1 | 0.0488952 |
MA0077.1 | 0.934844 |
MA0078.1 | 0.554788 |
MA0081.1 | 0.672921 |
MA0083.1 | 1.0158 |
MA0084.1 | 0.834984 |
MA0087.1 | 0.359239 |
MA0088.1 | 0.182616 |
MA0089.1 | 0 |
MA0090.1 | 0.199262 |
MA0091.1 | 0.986582 |
MA0092.1 | 0.232971 |
MA0093.1 | 0.110354 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.432601 |
MA0101.1 | 2.60341 |
MA0103.1 | 0.465544 |
MA0105.1 | 1.1776 |
MA0106.1 | 2.11396 |
MA0107.1 | 4.02458 |
MA0108.2 | 1.32368 |
MA0109.1 | 0 |
MA0111.1 | 0.21427 |
MA0113.1 | 0.961857 |
MA0114.1 | 0.791217 |
MA0115.1 | 0.592273 |
MA0116.1 | 0.550465 |
MA0117.1 | 0.416571 |
MA0119.1 | 0.346732 |
MA0122.1 | 0.438159 |
MA0124.1 | 0.555413 |
MA0125.1 | 1.21157 |
MA0130.1 | 0 |
MA0131.1 | 0.201414 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 0.410584 |
MA0136.1 | 1.35254 |
MA0139.1 | 0.00305399 |
MA0140.1 | 0.719477 |
MA0141.1 | 0.667208 |
MA0142.1 | 0.670879 |
MA0143.1 | 0.497764 |
MA0144.1 | 1.77852 |
MA0145.1 | 0.137416 |
MA0146.1 | 0.0435096 |
MA0147.1 | 0.0133837 |
MA0148.1 | 2.78817 |
MA0149.1 | 0.696747 |
MA0062.2 | 0.671388 |
MA0035.2 | 0.109476 |
MA0039.2 | 6.34635e-06 |
MA0138.2 | 0.190328 |
MA0002.2 | 1.41406 |
MA0137.2 | 1.7091 |
MA0104.2 | 0.00601882 |
MA0047.2 | 2.75738 |
MA0112.2 | 0.60016 |
MA0065.2 | 0.67817 |
MA0150.1 | 0.428432 |
MA0151.1 | 0 |
MA0152.1 | 0.113254 |
MA0153.1 | 0.467885 |
MA0154.1 | 1.42564 |
MA0155.1 | 0.0568093 |
MA0156.1 | 1.27602 |
MA0157.1 | 0.626418 |
MA0158.1 | 0 |
MA0159.1 | 0.851576 |
MA0160.1 | 1.1121 |
MA0161.1 | 0 |
MA0162.1 | 5.79688e-05 |
MA0163.1 | 0.00250554 |
MA0164.1 | 0.173709 |
MA0080.2 | 1.16388 |
MA0018.2 | 0.156863 |
MA0099.2 | 0.364364 |
MA0079.2 | 8.99802e-11 |
MA0102.2 | 0.870137 |
MA0258.1 | 0.440052 |
MA0259.1 | 0.014781 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
BATF#10538 | 7 | 5.16680644079168 | 0.00032624169049433 | 0.00332737850718138 |
BCL11A#53335 | 7 | 6.01776320379544 | 0.000128319363723114 | 0.00170568232504496 |
EBF1#1879 | 25 | 6.74732336861288 | 9.95619081306104e-18 | 2.14837729819273e-15 |
IRF4#3662 | 10 | 6.64076142022549 | 1.36753689995089e-06 | 5.32727289421748e-05 |
MEF2A#4205 | 11 | 6.24774363654802 | 6.4050131274486e-07 | 2.90840506964176e-05 |
MEF2C#4208 | 7 | 8.7630145893445 | 1.19086481273547e-05 | 0.000301071726403486 |
NFKB1#4790 | 24 | 3.99131885395915 | 1.22269380056977e-11 | 1.51659047313191e-09 |
PAX5#5079 | 11 | 2.22318851039261 | 0.00674900907940991 | 0.0286831512673757 |
POLR2A#5430 | 29 | 1.88715582182376 | 8.87752431645193e-07 | 3.82807498796831e-05 |
POU2F2#5452 | 9 | 2.48348837938432 | 0.00764962989900298 | 0.0315105978158071 |
SPI1#6688 | 14 | 3.48062209452479 | 1.33337707023643e-05 | 0.00032551792388598 |
ZEB1#6935 | 9 | 4.60593600478469 | 9.33815167125314e-05 | 0.00135698792596912 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.